Last reviewed · How we verify
NCT04747496: ETNA-AF-CHINA
Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China
trial testing Edoxaban in Non-valvular Atrial Fibrillation in 5,000 participants. Completed in 27 November 2024.
27 November 2024
Quick facts
| Lead sponsor | Daiichi Sankyo |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 5,000 |
| Start date | 26 February 2021 |
| Primary completion | 27 November 2024 |
| Estimated completion | 27 November 2024 |
| Sites | 97 locations across China |
Drugs / interventions tested
- Edoxaban (edoxaban) — full drug profile →
Conditions studied
- Non-valvular Atrial Fibrillation — all drugs for Non-valvular Atrial Fibrillation →
Sponsor
Daiichi Sankyo — full company profile →
Who can join
18 and older, any sex, with Non-valvular Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The safety of edoxaban treatment will be examined using real-world clinical evidence from adult patients with non-valvular atrial fibrillation (NVAF) indications in routine clinical practice.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Edoxaban for stroke prevention in atrial fibrillation and factors associated with dosing: patient characteristics from the prospective observational ETNA-AF-China registry.
Guo X, Du J, Yang Y, Wu M, et al · · 2024 · cited 2× · PMID 38307927 · DOI 10.1038/s41598-024-51776-3 -
Edoxaban for stroke prevention in Chinese patients with atrial fibrillation: 1-year follow-up of the ETNA-AF-China study.
Guo X, Du J, Yin Y, Qi H, et al · · 2026 · PMID 41660516 · DOI 10.3389/fphar.2026.1739246
Verify or expand the search:
- PubMed search for NCT04747496
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Edoxaban
Trials testing the same drug.
- NCT06285942 — EdOxaban in fRagIle Patients With Percutaneous Endoscopic GAstrostoMy and atrIal fIbrIllation · NA · unknown
- NCT06149533 — Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients · Phase 3 · not yet recruiting
- NCT05804747 — A Study to Evaluate Effectiveness and Safety of Edoxaban in Patients 80 Years of Age or Older With Nonvalvular Atrial Fi · completed
- NCT05732506 — Safety Evaluation of Edoxaban in Elderly Patients With Frailty Criteria · completed
- NCT05540587 — Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral Stenosis · Phase 2 · recruiting
Other recruiting trials for Non-valvular Atrial Fibrillation
Currently open trials in the same condition.
- NCT05565599 — An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Sub · NA · active not recruiting
Other Daiichi Sankyo trials
Trials by the same sponsor.
- NCT07474649 — A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events · Phase 3 · not yet recruiting
- NCT07206472 — A Study of Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Patients With Primary Hypercholestero · active not recruiting
- NCT07220616 — A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies · Phase 1, PHASE2 · recruiting
- NCT07268625 — Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid / Ezetimibe, and Atorv · Phase 1 · completed
- NCT07244341 — A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer ( · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04747496 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Daiichi Sankyo
- Last refreshed: 9 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04747496.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing